» Articles » PMID: 21163418

Maternal Outcome of Gestational Diabetes Mellitus

Overview
Journal Diabetes Metab
Specialty Endocrinology
Date 2010 Dec 18
PMID 21163418
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To estimate maternal outcome of treated or untreated gestational diabetes mellitus (GDM).

Methods: French and English publications were searched using PubMed and the Cochrane library.

Results: The diagnosis of GDM includes a high risk population for preeclampsia and Caesarean sections (EL3). The risks are positively correlated with the level of hyperglycaemia in a linear way (EL2). Intensive treatment of mild GDM compared with routine care reduces the risk of pregnancy-induced hypertension (preeclampsia, gestational hypertension). Moreover, it does not increase the risk of operative vaginal delivery, Caesarean section and postpartum haemorrhage (EL1). Being overweight, obesity and maternal hyperglycaemia are independent risk factors for preeclampsia (EL2). Their association with GDM increases the risk of preeclampsia and Caesarean section compared to diabetic women with a normal body mass index (EL3). The association of several risk factors (such as advanced maternal age, pre-existing chronic hypertension, pre-existing nephropathy, obesity, suboptimal glycaemic control) increases the risk of preeclampsia. In that case, the classic follow-up (blood pressure measurement, proteinuria) should be more frequent than monthly (professional consensus). The risk of Caesarean section is increased by macrosomia, whether suspected prenatally or not, but this increased risk remains whatever the birth weight (EL3). Diagnosis and treatment of GDM do not reduce the risk of severe perineal lesions, operative vaginal delivery and postpartum haemorrhage (EL2). Some psychological symptoms, such as anxiety and alteration of self-perception, can occur upon diagnosis of GDM (EL3). The treatment of GDM appears to reduce the risk of postpartum depression symptoms (EL2).

Conclusion: Most of the information published on GDM covers the risks of preeclampsia and Caesarean section; intensive care of GDM reduces these risks. Pregnancy care should be adjusted to the risk factors.

Citing Articles

Impact of experiencing multiple vulnerabilities on fetal growth and complications in women with hyperglycemia in pregnancy.

Bihan H, Nachtargeale C, Vicaud E, Sal M, Berkane N, Pinto S BMC Pregnancy Childbirth. 2023; 23(1):740.

PMID: 37853313 PMC: 10585815. DOI: 10.1186/s12884-023-06048-9.


Gut microbiome interacts with pregnancy hormone metabolites in gestational diabetes mellitus.

Lyu X, Wang S, Zhong J, Cai L, Zheng Y, Zhou Y Front Microbiol. 2023; 14:1175065.

PMID: 37492251 PMC: 10364628. DOI: 10.3389/fmicb.2023.1175065.


Association of the gene polymorphism with gestational diabetes mellitus in Chinese women.

Huang C, Guo Y, Li W, Xiang B, Zeng J, Zhou F BMJ Open Diabetes Res Care. 2023; 11(2).

PMID: 37055162 PMC: 10106001. DOI: 10.1136/bmjdrc-2022-003164.


Gut microbiota in women with gestational diabetes mellitus has potential impact on metabolism in pregnant mice and their offspring.

Qin S, Wang Y, Wang S, Ning B, Huai J, Yang H Front Microbiol. 2022; 13:870422.

PMID: 35992705 PMC: 9389115. DOI: 10.3389/fmicb.2022.870422.


The downregulation of miR-22 and miR-372 may contribute to gestational diabetes mellitus through regulating glucose metabolism via the PI3K/AKT/GLUT4 pathway.

Li W, Yuan X, He X, Yang L, Wu Y, Deng X J Clin Lab Anal. 2022; 36(7):e24557.

PMID: 35712865 PMC: 9279990. DOI: 10.1002/jcla.24557.